A gene therapy developed for babies with X-linked severe combined immunodeficiency (SCID‑X1) has substantially improved the immune function of all patients who received treatment, doctors reported last week.
Eight infants now have fully functionin...
5 years ago
An inhibitor that targets a specific mutation in relapsed or refractory acute myeloid leukaemia improves the survival rate of patients, a major conference has been told.
The phase III ADMIRAL trial, led by a team at the Abramson Cancer Center of t...
5 years ago
